Chemerin and Dermcidin in Human Milk and Their Alteration in Gestational Diabetes

Abstract

Background:

Chemerin and dermcidin, which have antimicrobial properties, are molecules that are also related to insulin resistance and inflammation.

Research aims:

The aims were to determine the amounts of chemerin and dermcidin in the milk and blood of mothers with gestational diabetes, and to compare the amounts of chemerin and dermcidin in the milk and blood of mothers with and without diabetes.

Methods:

This was a two-group nonrandomized longitudinal study with a convenience sampling of mothers without gestational diabetes (n = 27) and mothers with gestational diabetes (n = 26). Human milk and blood samples were obtained from these mothers during colostrum, transitional, and mature milk periods. The amount of chemerin and dermcidin in these samples was measured by enzyme-linked immunosorbent assay.

Results:

The presence of chemerin and dermcidin was first detected in human milk. The amounts of chemerin and dermcidin in the blood of all the mothers were greater in the colostrum period and lowest in the mature period. The amount of chemerin and dermcidin in the milk of all the mothers was greater than that in the blood. The amounts of chemerin and dermcidin were significantly increased in both blood and human milk within the gestational age samples.

Conclusions:

Chemerin and dermcidin may contribute to the protection of infants from infections during infancy. Increased amounts of these molecules found within the gestational diabetes group may also prevent adverse maternal and fetal outcomes.

Keywords

breastfeeding colostrum hormones human milk

Get full access to this article

View all access options for this article.

References

American Diabetes Association. (2018). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes. Diabetes Care, 41(Supplement 1), S13–S27. doi:10.2337/dc18-S002

Ashrafi

Sheikhan

Arabipoor

Rouhana

Hosseini

Zolfaghari

(2017). Gestational diabetes mellitus and metabolic disorder among the different phenotypes of polycystic ovary syndrome. Oman Medical Journal, 32(3), 214–220. doi:10.5001/omj.2017.40

Aydin

(2015). A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides, 72, 4–15. doi:10.1016/j.peptides.2015.04.012

Aydin

(2018). Gestational diabetes and peptides in breast milk. In Rajendram

Preedy

V. R.

Batel

V. B.

(Eds.), Nutrition and diet in maternal diabetes: An evidence-based approach, (pp. 367–383). Humana Press, Switzerland. doi:10.1007/978-3-319-56440-1_29

Bank

Ghosh

Jana

Bhattacharya

Sinha

A. K.

(2014). The diagnosis of high altitude illness by the determination of plasma dermcidin isoform 2 levels by enzyme linked immunosorbent assay. Clinical Laboratory, 60(7), 1187–1191.

Bhattacharya

Khan

M. M.

Ghosh

Bank

Maiti

(2017). The role of dermcidin isoform-2 in the occurrence and severity of diabetes. Scientific Reports, 7(1), 8252. doi:10.1038/s41598-017-07958-3

Burian

Schittek

(2015). The secrets of dermcidin action. International Journal of Medical Microbiology, 305(2), 283–286. doi: 10.1016/j.ijmm.2014.12.012

Butts

C. A.

Hedderley

D. I.

Herath

T. D.

Paturi

Glyn-Jones

Wiens

. . . Gopal

(2018). Human milk composition and dietary intakes of breastfeeding women of different ethnicity from the Manawatu-Wanganui Region of New Zealand. Nutrients, 10(9), 1231. doi:10.3390/nu10091231

Cacho

N. T.

Lawrence

R. M.

(2017). Innate immunity and breast milk. Frontiers in Immunology, 8, 584. doi:10.3389/fimmu.2017.00584

10.

Dritsakou

Liosis

Valsami

Polychronopoulos

Skouroliakou

(2017). The impact of maternal- and neonatal-associated factors on human milk’s macronutrients and energy. The Journal of Maternal-Fetal & Neonatal Medicine, 30(11), 1302–1308. doi:10.1080/14767058.2016.1212329

11.

El-Deeb

T. S.

Bakkar

S. M.

Eltoony

Zakhary

M. M.

Kamel

A. A.

Nafee

A. M

. . . Hetta

H. F.

(2018). The adipokine chemerin and fetuin-A serum levels in Type 2 diabetes mellitus: Relation to obesity and inflammatory markers. Egyptian Journal of Immunology, 25(1), 191–202.

12.

Fatima

S. S.

Khalid

Ladak

A. A.

Ali

S. A.

(2018). Colostrum and mature breast milk analysis of serum irisin and sterol regulatory element-binding proteins-1c in gestational diabetes mellitus. The Journal of Maternal-Fetal & Neonatal Medicine, 1–7. doi:10.1080/14767058.2018.1454422

13.

Ferland

D. J.

Watts

S. W.

(2015). Chemerin: A comprehensive review elucidating the need for cardiovascular research. Pharmacological Research, 99, 351–361. doi:10.1016/j.phrs.2015.07.018

14.

Garwolińska

Namieśnik

Kot-Wasik

Hewelt-Belka

(2018). Chemistry of human breast milk: A comprehensive review of the composition and role of milk metabolites in child development. Journal of Agricultural and Food Chemistry, 66(45), 11881–11896. doi:10.1021/acs.jafc.8b04031

15.

Hansen

M. U.

Gotland

Mejer

Petersen

Larsen

A. R.

Benfield

, & The Danish Staphylococcal Bacteremia Study Group. (2017). Diabetes increases the risk of disease and death due to Staphylococcus aureus bacteremia. A matched case-control and cohort study. Infectious Diseases, 49(9), 689–697. doi:10.1080/23744235.2017.1331463

16.

Hunter

R. W.

Hughey

C. C.

Lantier

Sundelin

E. I.

Peggie

Zeqiraj

. . . Sakamoto

(2018). Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nature Medicine, 24(9), 1395–1406. doi:10.1038/s41591-018-0159-7

17.

Jentsch

H. F. R.

Arnold

Richter

Deschner

Kantyka

Eick

(2017). Salivary, gingival crevicular fluid and serum levels of ghrelin and chemerin in patients with periodontitis and overweight. Journal of Periodontal Research, 52(6), 1050–1057. doi:10.1111/jre.12476

18.

Kaur

Mattu

H. S.

Chatha

Randeva

H. S.

(2018). Chemerin in human cardiovascular disease. Vascular Pharmacology, 110, 1–6. doi:10.1016/j.vph.2018.06.018

19.

Kennedy

A. J.

Davenport

A. P.

(2018). International Union of Basic and Clinical Pharmacology CIII: Chemerin receptors CMKLR1 (Chemerin [1]) and GPR1 Chemerin[2]) Nomenclature, Pharmacology, and Function. Pharmacological Reviews, 70(1), 174–196. doi:10.1124/pr.116.013177

20.

Mathieu

I. P.

Song

Jagasia

S. M.

(2014). Disparities in postpartum follow-up in women with gestational diabetes mellitus. Clinical Diabetes, 32(4), 178–182. doi:10.2337/diaclin.32.4.178

21.

Mazurier

Rigourd

Perez

Buffin

Couedelo

Vaysse

. . . Billeaud

(2017). Effects of maternal supplementation with omega-3 precursors on human milk composition. Journal of Human Lactation, 33(2), 319–328. doi:10.1177/0890334417691946

22.

Noel-Weiss

Boersma

Kujawa-Myles

(2012). Questioning current definitions for breastfeeding research. International Breastfeeding Journal, 7(1), 9.

23.

Ortega-Martínez

Gardeazabal

Erramuzpe

Sanchez-Diez

Cortés

García-Vázquez

M. D.

. . . Boyano

M. D.

(2016). Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma. International Journal of Cancer, 139(7), 1598–1607. doi:10.1002/ijc.30202

24.

Ortiz

F. M.

Jimenez

E. Y.

Boursaw

Huttlinger

(2016). Postpartum care for women with gestational diabetes. MCN: The American Journal of Maternal/Child Nursing, 41(2), 116–122. doi:10.1097/NMC.0000000000000215

25.

Popejoy

M. W.

Long

Huntington

J. A.

(2017). Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam. BMC Infectious Diseases, 17(1), 316. doi:10.1186/s12879-017-2414-9

26.

Ramasarma

Rafi

(2016). A glucose-centric perspective of hyperglycemia. Indian Journal of Experimental Biology, 54(2), 83–99.

27.

Roman

A. A.

Parlee

S. D.

Sinal

C. J.

(2012). Chemerin: A potential endocrine link between obesity and type 2 diabetes. Endocrine, 42(2), 243–251.

28.

Scarton

Prates

L. A.

Wilhelm

L. A.

Silva

S. C.

Possati

A. B.

Ilha

C. B.

. . . Ressel

L. B.

(2015). “It was worth it when I saw his face”: Experiences of primiparous women during natural childbirth. Revista Gaúcha de Enfermagem, 36, 143–151. doi:10.1590/1983-1447.2015.esp.56786

29.

Weng

Shen

Jiang

Peng

Yuan

. . . Wang

(2017). Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism. American Journal of Translational Research, 9(6), 3096–3104.

30.

Zhao

Y. H.

Chen

Y. P.

Yuan

X. L.

Wang

Zhu

. . . Lu

C. M.

(2014). Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: A systematic review and meta-analysis. Scientific World Journal, 926932. doi:10.1155/2014/926932

31.

Zabel

B. A.

Kwitniewski

Banas

Zabieglo

Murzyn

Cichy

(2014). Chemerin regulation and role in host defense. American Journal of Clinical and Experimental Medicine, 3(1), 1–19.

32.

Zeth

Sancho-Vaello

(2017). The human antimicrobial peptides dermcidin and LL-37 show novel distinct pathways in membrane interactions. Frontiers in Chemistry, 5, 86. doi:10.3389/fchem.2017.00086

33.

Zhang

Wang

(2018). Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. Experimental and Therapeutic Medicine, 15(3), 2936–2940. doi:10.3892/etm.2018.575